Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Newsletter

Wednesday, 5th January 2022

by Sumit Chanda
January 5, 2022
in Newsletter
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

In a setback to the Future group, the Delhi High Court refused to interfere in the decision making powers of the SIAC. Future had moved to terminate the arbitration proceedings at the SIAC. However, that has now been struck down by the Delhi High Court. Amazon had sought arbitration at Singapore International Arbitration Centre (SIAC) alleging that FRL had violated the ROFR given to Amazon. Last month, the CCI had suspended its approval for Amazon’s purchase of Future Coupons, but the last word will be from SIAC. 

For FY21, Flipkart India reported 25% higher revenues of Rs.43,357 crore. However, the net loss for the year stood at Rs.2,445 crore. The company has reported an additional net loss of Rs.2,881 crore under Flipkart Internet. Currently, Flipkart is engaged in a fierce battle for the online marketplace with Amazon and Reliance JioMart. However, with the backing of Wal-Mart, Flipkart has the required pockets to match up to Amazon. The gross merchandise value (GMV) during the festival season grew by 23% yoy this year.

It looks like sugar companies are once again in a sweet spot as is evident from the slew of sugar stocks that are recording new highs on a regular basis. Most of the sugar stocks like Triveni Engineering, Balrampur Chini and many other sugar companies scaled new yearly highs. This season, sugar prices are expected to rise 16-17% due to a pickup in industrial demand and higher exports. A sharp fall in inventory levels is also likely to help sugar prices sustain. Ethanol blending is the other big opportunity in sugar.

HDFC Bank loan book grew 16.4% in the De-21 quarter to Rs.12.6 trillion. The retail loan book showed a much more robust growth at 13.5% on a yoy basis and 4.5% on a sequential basis. The growth in corporate and wholesale loans was relatively more muted at 7.5% on a yoy basis. The deposit base of HDFC Bank saw growth of 13.8% at Rs.14.46 trillion, with retail deposits growing by 17% on yoy basis against flat wholesale deposits. CASA deposits grew 43% yoy and accounts for 47% of the deposit base of HDFC Bank.

In a sigh of relief for Hindustan Unilever, the All India Consumer Products Distributors Federation called off the boycott of HUL products. This was after HUL met the representatives of the Union and assured that their demands would be addressed. The traditional distributors had an objection to better terms being offered to the new B2B platforms like Jio and Metro Cash and Carry. However, the issue with Colgate is yet to be resolved and for now the boycott continues. AICPDF will not stock Colgate products in Mumbai.

Reddy Labs will launch Molflu (Molnupiravir) at Rs.35 per capsule to treat COVID-19. The COVID course comprises of 40 tablets over 5 days so the total medicine cost would be Rs.1,400 which makes it a lot more affordable. Molflu will be available in pharmacies from next week. Reddy Labs has already signed a non-exclusive licensing agreement with Merck Sharpe Dohme (MSD) to manufacture Molnupiravir in India. Reddy Labs has received emergency-use authorisation from the DCGI to market Molnupiravir.

In the calendar year 2021, India spent $55.7 billion on gold imports, double of 2020 and even higher than the record $53.9 billion spent in year 2011. In a way, the price drop also helped to boost the demand for gold even as jewellers were aggressively stocking up on gold ahead of the festival season in 2021. In volume terms, gold imports stood at 1,050 tonnes in 2021 compared to just 430 tonnes in 2020. Domestic gold prices scaled Rs.56,191/10gm in Aug-20 but fell to Rs.43,320/10gm in Mar-21, boosting gold demand. 

ICRA expects India’s pharma industry to grow at 9-11% in FY22, driven by robust demand from emerging markets. In Q2, revenue growth stood at 6.4%. The demand momentum was impacted by normalisation of the base and pricing pressures in the US market. While EMs will see 13-15% growth, Indian markets will see 14-16% while Europe will grow 9-11% in FY22. This was evident in the second quarter, with the EMs clocking 30.6% sales growth. ICRA also expects the operating markets and net margins to be robust.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Related Posts

SmallCap and Midcap-Stocks-Surge-Buy-Now-or-Hold

Smallcap & Midcap Stocks Surge: Buy Now or Hold?

by Sumit Chanda
July 28, 2025
0
5.3k

The year 2025 has begun on a difficult note for investors in small and midcap stocks. The Nifty Midcap 150...

Pharma Sector Stocks to invest in 2025

Pharma Sector in 2025 : Best Pharma Stocks for Profit & Growth

by Sumit Chanda
July 25, 2025
0
5.3k

The drug business is quick in 2025. New drugs are being approved more often. Corporations are also trying new methods...

Indian IT Stocks vs Global IT stocks - where to invest now

IT Sector Stocks vs Global Tech: Where to Invest Now?

by Sumit Chanda
July 24, 2025
0
5.3k

The technology sector has proven to be one of the most powerful engines of wealth creation globally. From India’s IT...

Metal Stocks Soar – Is This the Right Time to Invest?

Metal Stocks Soar – Is This the Right Time to Invest?

by Sumit Chanda
July 23, 2025
0
5.3k

In 2025, the Indian metal sector is doing well. Metal stocks have gone up, and many investors are showing interest....

Quarterly Results Q1 FY26 Nifty 50 company results

Quarterly Results: Nifty 50 Q1 FY26 Growth Snapshot

by Sumit Chanda
July 22, 2025
0
5.3k

India has started the first quarter of the financial year FY26. Many people are now watching the Nifty 50 earnings...

Oil and Gas Companies

Oil and Gas Companies to watch in Volatile Market

by Sumit Chanda
July 21, 2025
0
5.3k

Oil price swings, geopolitical tensions, and energy transition pressures are the news every other day. However, India’s oil & gas...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Equity Market
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Interesting Read
  • Financial Planning
  • Portfolio Management
  • Newsletter
Connect with us: customersupport@jarvisinvest.com

© 2023 Jarvis Invest

No Result
View All Result
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version